BDBM50247927 CHEMBL489706::N-hydroxy-3-(2-phenethyl-1-(pyridin-2-ylmethyl)-1H-benzo[d]imidazol-5-yl)acrylamide::US10201527, Compound 16::US10736881, Compound 16::US8551988, 16

SMILES: ONC(=O)\C=C\c1ccc2n(Cc3ccccn3)c(CCc3ccccc3)nc2c1

InChI Key: InChIKey=AIVHKZVAUIOORN-SDNWHVSQSA-N

Data: 7 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 50247927   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Histone deacetylase 8 (Homo sapiens (Human))	BDBM50247927 (CHEMBL489706 | N-hydroxy-3-(2-phenethyl-1-(pyridin...) Show SMILES ONC(=O)\C=C\c1ccc2n(Cc3ccccn3)c(CCc3ccccc3)nc2c1 Show InChI InChI=1S/C24H22N4O2/c29-24(27-30)14-11-19-9-12-22-21(16-19)26-23(13-10-18-6-2-1-3-7-18)28(22)17-20-8-4-5-15-25-20/h1-9,11-12,14-16,30H,10,13,17H2,(H,27,29)/b14-11+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	US Patent	n/a	n/a	366	n/a	n/a	n/a	n/a	n/a	n/a
Mei Pharma, Inc. US Patent					Assay Description The assay have been carried out in a 96 well format and the BIOMOL using a fluorescent-based HDAC activity assay.				US Patent US8551988 (2013) BindingDB Entry DOI: 10.7270/Q2BZ64P8
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM50247927 (CHEMBL489706 | N-hydroxy-3-(2-phenethyl-1-(pyridin...) Show SMILES ONC(=O)\C=C\c1ccc2n(Cc3ccccn3)c(CCc3ccccc3)nc2c1 Show InChI InChI=1S/C24H22N4O2/c29-24(27-30)14-11-19-9-12-22-21(16-19)26-23(13-10-18-6-2-1-3-7-18)28(22)17-20-8-4-5-15-25-20/h1-9,11-12,14-16,30H,10,13,17H2,(H,27,29)/b14-11+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	US Patent	n/a	n/a	194	n/a	n/a	n/a	n/a	n/a	n/a
Mei Pharma, Inc. US Patent					Assay Description The assay have been carried out in a 96 well format and the BIOMOL using a fluorescent-based HDAC activity assay.				US Patent US8551988 (2013) BindingDB Entry DOI: 10.7270/Q2BZ64P8
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM50247927 (CHEMBL489706 | N-hydroxy-3-(2-phenethyl-1-(pyridin...) Show SMILES ONC(=O)\C=C\c1ccc2n(Cc3ccccn3)c(CCc3ccccc3)nc2c1 Show InChI InChI=1S/C24H22N4O2/c29-24(27-30)14-11-19-9-12-22-21(16-19)26-23(13-10-18-6-2-1-3-7-18)28(22)17-20-8-4-5-15-25-20/h1-9,11-12,14-16,30H,10,13,17H2,(H,27,29)/b14-11+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	250	n/a	n/a	n/a	n/a	n/a	n/a
S *BIO Pte Ltd Curated by ChEMBL					Assay Description Inhibition of recombinant HDAC1 by fluorimetric assay				Bioorg Med Chem Lett 19: 1403-8 (2009) Article DOI: 10.1016/j.bmcl.2009.01.041 BindingDB Entry DOI: 10.7270/Q2FT8KX3
					More data for this Ligand-Target Pair
Histone deacetylase 8 (Homo sapiens (Human))	BDBM50247927 (CHEMBL489706 | N-hydroxy-3-(2-phenethyl-1-(pyridin...) Show SMILES ONC(=O)\C=C\c1ccc2n(Cc3ccccn3)c(CCc3ccccc3)nc2c1 Show InChI InChI=1S/C24H22N4O2/c29-24(27-30)14-11-19-9-12-22-21(16-19)26-23(13-10-18-6-2-1-3-7-18)28(22)17-20-8-4-5-15-25-20/h1-9,11-12,14-16,30H,10,13,17H2,(H,27,29)/b14-11+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	US Patent	n/a	n/a	366	n/a	n/a	n/a	n/a	n/a	n/a
MEI Pharma, Inc. US Patent									US Patent US10736881 (2020)
					More data for this Ligand-Target Pair
Histone deacetylase 8 (Homo sapiens (Human))	BDBM50247927 (CHEMBL489706 | N-hydroxy-3-(2-phenethyl-1-(pyridin...) Show SMILES ONC(=O)\C=C\c1ccc2n(Cc3ccccn3)c(CCc3ccccc3)nc2c1 Show InChI InChI=1S/C24H22N4O2/c29-24(27-30)14-11-19-9-12-22-21(16-19)26-23(13-10-18-6-2-1-3-7-18)28(22)17-20-8-4-5-15-25-20/h1-9,11-12,14-16,30H,10,13,17H2,(H,27,29)/b14-11+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	US Patent	n/a	n/a	366	n/a	n/a	n/a	n/a	n/a	n/a
MEI PHARMA, INC. US Patent					Assay Description To determine EC50 where acetylated histone 3 was induced by 50%, Colo205 cells was cultivated in 96 well plate at 1.5×105 cells/well for 24 h. Colo20...				US Patent US10201527 (2019) BindingDB Entry DOI: 10.7270/Q2PK0J7F
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM50247927 (CHEMBL489706 | N-hydroxy-3-(2-phenethyl-1-(pyridin...) Show SMILES ONC(=O)\C=C\c1ccc2n(Cc3ccccn3)c(CCc3ccccc3)nc2c1 Show InChI InChI=1S/C24H22N4O2/c29-24(27-30)14-11-19-9-12-22-21(16-19)26-23(13-10-18-6-2-1-3-7-18)28(22)17-20-8-4-5-15-25-20/h1-9,11-12,14-16,30H,10,13,17H2,(H,27,29)/b14-11+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	US Patent	n/a	n/a	194	n/a	n/a	n/a	n/a	n/a	n/a
MEI Pharma, Inc. US Patent					Assay Description The assay has been carried out in 96 well format and the BIOMOL fluorescent-based HDAC activity assay has been applied. The reaction composed of assa...				US Patent US10736881 (2020)
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM50247927 (CHEMBL489706 | N-hydroxy-3-(2-phenethyl-1-(pyridin...) Show SMILES ONC(=O)\C=C\c1ccc2n(Cc3ccccn3)c(CCc3ccccc3)nc2c1 Show InChI InChI=1S/C24H22N4O2/c29-24(27-30)14-11-19-9-12-22-21(16-19)26-23(13-10-18-6-2-1-3-7-18)28(22)17-20-8-4-5-15-25-20/h1-9,11-12,14-16,30H,10,13,17H2,(H,27,29)/b14-11+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	US Patent	n/a	n/a	194	n/a	n/a	n/a	n/a	n/a	n/a
MEI PHARMA, INC. US Patent					Assay Description The assay has been carried out in 96 well format and the BIOMOL fluorescent-based HDAC activity assay has been applied. The reaction composed of assa...				US Patent US10201527 (2019) BindingDB Entry DOI: 10.7270/Q2PK0J7F
					More data for this Ligand-Target Pair